flipper44
8 minutes ago
To me, we should be discussing market cap. Like over a decade ago, two Car-T companies went for just over and just und 10 billion. DCVax has a larger potential production capacity, manufacturing cost profit margin with automation, indication expansion potential, efficacy increase potential, known